TROPION-Lung12 Phase 3 Trial Initiated Evaluating DATROWAY ® as Part of Adjuvant Regimen for Patients with Early-Stage Non-Small Cell Lung Cancer at High Risk of Relapse

TROPION-Lung12 Phase 3 Trial Initiated Evaluating DATROWAY ® as Part of Adjuvant Regimen for Patients with Early-Stage Non-Small Cell Lung Cancer at High Risk of Relapse#TROPIONLung12 #Phase #Trial #Initiated #Evaluating #DATROWAY #Part #Adjuvant #Regimen #Patients #EarlyStage #NonSmall #Cell #Lung #Cancer #High #Risk #Relapse